Artificial intelligence (AI) systems are now widely used by millions of people worldwide, as tools to source information or ...
Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...